MJ Business Attorneys

OCTOBER 26, 2017

She came to the industry not from the recreational side, but as a mother seeking treatment for her child with epilepsy. In 2014, I was reading the Senate Bill 339 [Texas’ Compassionate Use Act enacted in 2015] testimony of mothers of children with epilepsy. This law was passed in 2015. That just lit the fire under me.

Epilepsy 100

Epilepsy Recreational Treatment Programs 100

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Following the treatment period, there was a 35.5% Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JUNE 25, 2021

The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. MorphoSys and LEO Pharma strategically worked together to develop antibodies pertaining to the treatment of skin cancer. Executive Summary.

Research and Development 65

Research and Development Therapy Pharmaceutical Clinical Trials 65

The Joint Blog

JUNE 28, 2019

According to new research, the use of marijuana is a safe and effective treatment for those with fibromyalgia. The study, titled Safety and efficacy of medical cannabis in fibromyalgia, was published by the Journal of Clinical Medicine and was published online by the U.S. 0.72), concerns about cannabis treatment (OR 0.36, 95% C.I

Therapy 44

Therapy Treatment Chronic Pain Marijuana 44

Cannabis Law Report

JUNE 7, 2021

million) | Tax rate: 37% at retail since July 2015; 6.5% Until July 2015, taxes were quite high — 25% at three points of transfer — making it hard to compete with illegal sales. In addition to changing the tax rate to 37% in 2015, the legislature created a medical endorsement program to which adult-use stores could apply to join.

Marijuana 91

Marijuana Retail Collective Programs 91

Dykema (Cannabis Law Blog)

APRIL 20, 2023

The medicinal use of cannabis in the Texas Compassionate Use Act (the “Act”, 2015), provides for the medical sale and use of cannabis for individuals with specific defined illnesses. Health & Safety Code § 487.001 et seq. [iv] Specifically, H.B. iv] Texas State Law Library – Cannabis and the Law – [link]. [v] vi] [link] [vii] Tex.

Law 74

Law Chronic Pain Conditions Medicine 74

Cannabis Law Report

JUNE 14, 2022

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. Psychedelic compounds – such as psilocybin and MDMA – are one such extremely promising area.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

JULY 28, 2021

Today’s patchwork of inconsistent, and often contradictory, state regulations — coupled with the lack of methodical testing and safety requirements — is calling consumer protection into question. To date, 81 warning letters have been sent since 2015. The safety of CBD is also a primary concern. Skin health or acne treatment.

CBD 75

CBD Food Treatment Conditions 75

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Veriheal

OCTOBER 27, 2023

The duo’s study is built on the back of genetic sequencing research published in 2015 — which Edsinger himself contributed to. Others, meanwhile, fear that these restrictions will drive the industry underground making product regulation and safety all the more difficult. So, what’s the alternative?

Decriminalization 64

Decriminalization Treatment Therapy Legislation 64

Veriheal

AUGUST 9, 2024

Migraine treatments can often be unsuccessful so the fact that cannabis and psilocybin present as potentially effective treatments is quite important for those in need of relief. That being said, let’s have a look at the study which found the promise of psilocybin for long-lasting therapeutic benefits.

Treatment 52

Treatment Microdosing Therapy Patients 52

Cannabis Law Report

JANUARY 23, 2020

the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. 2015/2283 of the European Parliament and of the. Council of 25 November 2015 relating to novel foods and which. food): «Scientific Opinion on the safety of hemp (Cannabis. 2 of Regulation (EC) no.

Food 45

Food THC Safety Agriculture 45

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. California has long been a pioneer in the field of medical marijuana, and its MMJ laws have continued to evolve over the years.

Patients 52

Patients Law Cultivation Dispensary 52

Cannabis Law Report

JUNE 7, 2019

. “Cannabis is clearly addictive and harmful, and there is no scientific evidence of the safety and efficacy of raw cannabis use,” the statement said. A 2015 literature review done by experts from Singapore’s Institute of Mental Health affirmed the harmful and addictive nature of unprocessed, or raw, cannabis.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

The Blunt Truth

JULY 5, 2023

Dish Network, LLC (Colorado 2015) and Ceballos v. Starting August 1, 2023, whether and when a Minnesota employer can test for cannabis will depend on either the position at issue or the type of testing sought ( e.g. , pre-employment, random, reasonable suspicion or treatment program). NP Palace, LLC (Nevada 2022).

Law 52

Law Recreational Policy Treatment 52

MMJ Recs

DECEMBER 13, 2023

However, the tide began to turn in 2015 when the state legislature passed the Compassionate Use Act, allowing for the limited use of low-THC cannabis for patients with intractable epilepsy. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

AUGUST 23, 2022

The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. By Jennifer L. Mora on August 22, 2022. Last month, on July 13, 2022, Washington, D.C. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C.

Safety 52

Safety Environment Policy Recreational 52

Cannabis Law Report

MARCH 30, 2022

And while there are many effective treatments available, some people still struggle to find relief. Anecdotal evidence does indicate that many people who suffer from depression find CBD a useful addition to their treatment plan. . This is where CBD comes in. Research About CBD And Anxiety.

CBD 52

CBD Sleep Digestion Treatment 52

MMJ Recs

MAY 5, 2024

California Medical Marijuana Legislation Explained The current regulatory framework for medical marijuana in California is primarily governed by the Medical Cannabis Regulation and Safety Act (MCRSA) and the Adult Use of Marijuana Act (AUMA), also known as Proposition 64.

Law 52

Law Marijuana Cultivation Patients 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. Results of the treatment.

Oil 40

Oil Treatment Patients THC 40

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Following the treatment period, there was a 35.5% Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

JANUARY 9, 2022

million) | Tax rate: 37% at retail since July 2015; 6.5% Until July 2015, taxes were quite high — 25% at three points of transfer — making it hard to compete with illegal sales. In addition to changing the tax rate to 37% in 2015, the legislature created a medical endorsement program to which adult-use stores could apply to join.

Collective 52

Collective Policy Retail Programs 52

Greencamp

SEPTEMBER 12, 2018

When it comes to medical treatment, the most common options are SSRIs and antipsychotics. In a 2015 statement, the Canadian Pediatric Society said that “there is little data to support either the efficacy or safety of cannabis use for any indications in children.”. Is it ethical to treat children with medical cannabis?

Strains 76

Strains Research and Development Marijuana Therapy 76

Kind Meds (Cannabis Education Blog)

SEPTEMBER 2, 2022

When these functions are impaired, even slightly, it poses a serious safety risk. Marijuana has proven to be a beneficial treatment for a significant number of medical conditions. Be required to undergo screening and treatment. Undergo screening and treatment. Undergo screening and treatment. 2] Pearlson, G.

Law 52

Law Marijuana Treatment Recreational 52

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Health and safety standards for lab employees. since 2015. Kristin Jordan.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns.

THC 52

THC CBD Media Food 52

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Kind Meds (Cannabis Education Blog)

MARCH 25, 2022

Cannabidiol as a Potential Treatment for Anxiety Disorders. Once you are in the safety of your own privacy, you can use the purchased cannabis products from the dispensary. Cannabidiol as a Potential Treatment for Anxiety Disorders. 2] Blessing, E. Steenkamp, M. Manzanares, J., & Marmar, C. Do Some Research. Steenkamp, M.

Dispensary 52

Dispensary Edibles Strains Vaping 52

Cannabis Law Report

JANUARY 16, 2020

Devonian’s core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis. Devonian Health Group Inc. Devonian Health Group Inc. Acquired in 2018, Altius Healthcare Inc.,

Extraction 49

Extraction Pharmaceutical Research and Development Terpenes 49

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. EU Regulation 2015/2283 of the European Union (the Novel Foods Regulation) regulates “novel foods”. The Regulations define a CBPM as a preparation or product that. (a) Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

JULY 18, 2019

On April 15, 2019, Florida released updated Information on How to Get Medical Marijuana Treatment Center License , or MMTC license, in the state to open a clinic or dispensary. . In 2015 he sponsored a House bill to expand Florida’s Right to Try Act to include medical marijuana. ” Almut Winterstein, Ph.D.,

Marijuana 40

Marijuana Dispensary Research and Development Patients 40

Cannabis Law Report

JULY 31, 2019

3] The CSA established five schedules of controlled substances, with Schedule I substances defined as those which have a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. [4] Health and Safety Code § 11362.5. [7] 801, et seq. [4]

Law 40

Law Legalization Marijuana Policy 40

Cannabis Law Report

SEPTEMBER 3, 2019

The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Federal legislation to enable the production and sale of cannabis for medical use and related research purposes was passed by Australia’s parliament in 2016. Australian Leadership Appointments.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

JULY 9, 2019

The ministry considers extracts containing cannabinoid used in food (primarily in food supplements such as CBD oil) generally as novel food according to Regulation (EU) 2015/2283 and therefore not marketable, since there is no marketing authorization for such products. food/safety/novel_food/catalogue/search/public/index.cfm#.

Food 40

Food Seed-To-Sale Sativa Extraction 40

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. Compensation is not payable for treatments that “simply improve the plaintiff’s enjoyment of life” 32.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45